Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
about
Germline Genetic Variants in TEK, ANGPT1, ANGPT2, MMP9, FGF2 and VEGFA Are Associated with Pathologic Complete Response to Bevacizumab in Breast Cancer Patients.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@ast
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@en
type
label
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@ast
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@en
prefLabel
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@ast
Germline Genetic Variants in T ...... mab in Breast Cancer Patients.
@en
P2093
P2860
P1433
P1476
Germline Genetic Variants in T ...... umab in Breast Cancer Patients
@en
P2093
Eric R Siegel
Ishwori Dhakal
Jeannette Y Lee
Laura F Hutchins
Mohammed S Orloff
Robert J Griffin
Ronda S Henry-Tillman
Stephen W Erickson
Susan A Kadlubar
Suzanne Klimberg
P2860
P304
P356
10.1371/JOURNAL.PONE.0168550
P407
P577
2017-01-03T00:00:00Z